Effects of lycopene on proliferation and death of canine osteosarcoma cells

American Journal of Veterinary Research

Volumn 71, Issue 11, 2010, Pages 1362-1370

  Wakshlag, Joseph J ^a   Balkman, Cheryl E ^a  

^a Department of Molecular Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LYCOPENE; PROTEIN BID; PROTEIN KINASE B;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME PHOSPHORYLATION; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PROTEIN EXPRESSION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CAROTENOIDS; CELL CYCLE; CELL DIVISION; DOG DISEASES; DOGS; DOXORUBICIN; FLOW CYTOMETRY; MITOCHONDRIA; OSTEOSARCOMA;

CANIS FAMILIARIS;

EID: 78149379720     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.11.1362     Document Type: Article

References (29)

1. Nishino H, Satomi Y, Tokuda H, et al. Cancer control by phytochemicals. Curr Pharm Des 2007;13:3394-3399.
2. Pan MH, Ho CT. Chemopreventative effects of natural dietary compounds on cancer development. Chem Soc Rev 2008;37:2558-2574.
3. Raghavan M, Knapp DW, Bonney PL, et al. Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 2005;227:94-100.
4. Lana SE, Kogan LR, Crump KA, et al. The use of complementary and alternative therapies in dogs and cats with cancer. J Am Anim Hosp Assoc 2006;42:361-365.
5. Wertz K, Siler U. Goralcyk. Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 2004;430:127-134.
6. Stacewicz-Sapuntzakis M, Bowen PE. Role of lycopene and tomato products in prostate health. Biochim Biophys Acta 2005;1740:202-205.
7. van Breeman RB, Pajkovic N. Multitargeted therapy of cancer by lycopene. Cancer Lett 2008;269:339-351.
8. Seren S, Lieberman R, Bayraktar UD. Lycopene in cancer prevention and treatment. Am J Ther 2008;15:66-91.
9. Mein JR, Lian F, Wang XD. Biological activity of lycopene metabolites: implications for cancer progression. Nutr Rev 2008;66:667-683.
10. Korytko PJ, Rodvold KA, Crowell JA et al. Pharmacokinetics and tissue distribution of orally administered lycopene in male dogs. J Nutr 2003;133:2788-2792.
11. Vertzoni M, Valsami G, Reppas C. Plasma profiles of lycopene after single oral and intravenous administrations in dogs. J Pharm Pharmacol 2006;58:1211-1217.
12. Liu A, Pajkovic N, Pang Y, et al. Absorption and subcellular localization of lycopene in human prostate cancer cells. Mol Cancer Ther 2006;5:2879-2885.
13. Ivanov NI, Cowell SP, Brown P, et al. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and independent prostate cancer cell lines. Clin Nutr 2007;26:252-263.
14. Limpens J, Schroder FH, de Ridder CM, et al. Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice. J Nutr 2006;136:1287-1293.
15. Siler U, Spitzer V, Lein M, et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J 2004;18:1019-1021.
16. Hantz HL, Young LF, Martin KR. Physiologically attainable concentration of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med 2005;230:171-179.
17. Salman H, Bergman M, Djaldetti M, et al. Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed Pharmacother 2007;61:366-369.
18. Liu C, Lian F, Smith DE, et al. Lycopene supplementation inhibits lung squamous metaplasia and induces apotosis via upregulating insulin-line growth factor binding protein 3 in cigarette smoke exposed ferrets. Cancer Res 2003;63:3138-3144.
19. Nahum A, Hirsch K, Danilenko M, et al. Lycopene inhibition of cell cycle progression in breast and endometrial cells is associated with reduction in cyclin D levels and retention of p27 in the cyclinE-cdk2 complexes. Oncogene 2001;20:3428-3436.
20. Tang FY, Shih CJ, Cheng LH, et al. Lycopene inhibits growth of human colon cancer cells via suppression of the AKT signaling pathway. Mol Nutr Food Res 2008;52:646-654.
21. Mueller F, Fuchs B, Kaser-Hotz B. Comparative biology of canine and human osteosarcoma. Anticancer Res 2007;27:155-164.
22. Cooney RV, Kappock TJ, Pung A, et al. Solubilization, cellular uptake, and activity of β-carotene and other carotenoids as inhibitors of neoplastic transformation in cell culture. Methods Enzymol 1993;214:55-68.
23. Amano Y, Fukumoto S. A study on the cell kinetics of the canine mucosa by the cytofluorometric method: an evaluation of chemically induced gastric cancer. Gastroenterol Jpn 1987;22:292-302.
24. Antonyak MA, Miller AM, Jansen JM, et al. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem 2004;279:41461-41467.
25. Wang JB, Wu WJ, Cerione RA. Cdc42 and Ras cooperate to mediate cellular transformation by intersectin-L. J Biol Chem 2005;280:22883-22891.
26. Burgess LC, Rice E, Fischer T, et al. Lycopene has limited effect on cell proliferation in only two of seven human cell lines in an in-vitro system with doses across the physiologic range. Toxicol In Vitro 2008;22:1297-1300.
27. Wakshlag JJ, Kallfelz FA, Wakshlag RR, et al. The effects of branched chain amino acids on canine neoplastic cell growth. J Nutr 2006;136:2007S-2010S.
28. Wong WW, Puthalakath H. Bcl-2 family protein: the sentinels of the mitochondrial apoptosis pathway. Life 2008;60:390-397.
29. Kang MH, Reynolds P. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009;15:1126-1132.